#United States #Austin #Life Sciences #Pharmacovigilance #Oracle

Oracle's Recognition in Pharmacovigilance Technology

On September 30, 2025, Oracle was named a leader in the 2025 IDC MarketScape for its advanced technology solutions and consulting services in the arena of worldwide Life Science Research and Development (R&D) pharmacovigilance. The IDC MarketScape recognized Oracle's efforts in integrating its various platforms, such as the Safety One Platform, Oracle Real-World Data (ORWD), Health Data Intelligence (HDI) platform, and Oracle Cloud Infrastructure (OCI) AI Services, to create a comprehensive strategy for precision pharmacovigilance (PV).

According to Dr. Nimita Limaye, the research vice president of Life Sciences R&D Strategy and Technology at IDC, "Oracle is building a connected ecosystem for precision PV by harmonizing its solutions for safety, data, and intelligence." This strategic integration not only demonstrates Oracle's regulatory expertise but also positions the company favorably in guiding the industry towards improved drug safety management.

Seema Verma, Oracle's executive vice president and general manager, expressed pride in the organization's significant contributions to drug safety innovation. She highlighted that Oracle's investments in research and development are pivotal in supporting clients to navigate the complexities of bringing life-saving treatments to market efficiently and safely. Verma remarked, "This recognition emphasizes our commitment to ensuring that organizations are prepared for the evolving landscape of regulatory challenges and safety considerations."

The IDC MarketScape report notes that Oracle has offered pharmacovigilance technology solutions for nearly three decades. The company anticipates a 20% annual growth in its PV revenue over the next three years and currently holds around 60% of the PV software market share. Furthermore, Oracle has successfully facilitated over 100,000 clinical trials, with 90% focused on PV aspects, gaining over 400 direct PV customers and acquiring nearly 100 new customers in the last year alone. Notably, it reports that over 70% of all Individual Case Safety Reports (ICSRs) submitted to the FDA since 2017 have originated from Oracle's Argus system.

By continuously innovating and delivering advanced AI-powered solutions, Oracle allows its clients to streamline pharmacovigilance operations and uphold high patient safety standards. This not only enhances operational efficiency but also ensures that the highest standards of care are maintained.

For those interested in exploring more about the 2025 IDC MarketScape and its findings on pharmacovigilance technology solutions and consulting services, additional excerpts can be accessed at Oracle's Life Sciences Safety Solutions.

Understanding IDC MarketScape

The IDC MarketScape is a vendor assessment model offering insights into the competitive strengths of technology and service suppliers across specific markets. It employs a rigorous scoring methodology based on qualitative and quantitative criteria, culminating in a graphical depiction of each supplier's standing within that market. This comprehensive framework enables technology buyers to evaluate suppliers' strengths and weaknesses holistically.

About Oracle Life Sciences

Oracle Life Sciences stands as a frontrunner in cloud technology applications tailored for pharmaceutical research and consulting. It is trusted globally by professionals in both large and emerging companies involved in clinical research and pharmacovigilance, spanning both pre- and post-drug launch stages. With over 20 years of industry experience, Oracle Life Sciences strives to signficantly enhance clinical development processes, leveraging real-world evidence to foster innovation and expedite advancements in the field, ultimately leading to improved patient outcomes. For further details regarding Oracle and its life sciences offerings, visit www.oracle.com/life-sciences.

About Oracle

Oracle Corporation is known for providing integrated application suites alongside secure, autonomous infrastructure via the Oracle Cloud. To learn more about Oracle, please visit Oracle.